|
|
|
|
Other NAP books related by word and phrase frequencies
The following titles are likely to be of interest to you. The top
keyword and keyphrase weights from this report have been compared with the
equivalent lists of words and phrases for all other available NAP
publications.
- Perspectives on Biomarker and Surrogate Endpoint Evaluation:Discussion Forum Summary (ISBN ) Alison Mack, Erin Balogh, and Christine Micheel, Rapporteurs; Committee on Qualification of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine
- Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease (ISBN ) Christine M. Micheel and John R. Ball, Editors; Committee on Qualifications of Biomarkers and Surrogate Endpoints in Chronic Disease; Institute of Medicine
- Evolution of Translational Omics: Lessons Learned and the Path Forward (ISBN ) Christine M. Micheel, Sharly J. Nass, and Gilbert S. Omenn, Editors; Committee on the Review of Omics-Based Tests for Predicting Patient Outcomes in Clinical Trials; Board on Health Care Services; Board on Health Sciences Policy; Institute of Medicine
- Cancer Biomarkers: The Promises and Challenges of Improving Detection and Treatment (ISBN ) Committee on Developing Biomarker-Based Tools for Cancer Screening, Diagnosis, and Treatment, Sharyl J. Nass and Harold L. Moses, Editors
- A National Cancer Clinical Trials System for the 21st Century:Reinvigorating the NCI Cooperative Group Program (ISBN ) Sharyl J. Nass, Harold L. Moses, and John Mendelsohn, Editors; Committee on Cancer Clinical Trials and the NCI Cooperative Group Program; Institute of Medicine
- Facilitating Collaborations to Develop Combination Investigational Cancer Therapies: Workshop Summary (ISBN ) Margie Patlak, Erin Balogh, and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine
- Improving the Quality of Cancer Clinical Trials:Workshop Summary (ISBN ) Margie Patlak and Sharyl Nass, Rapporteurs
- Accelerating the Development of Biomarkers for Drug Safety:Workshop Summary (ISBN ) Steve Olson, Sally Robinson, and Robert Giffin, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Institute of Medicine
- Neuroscience Biomarkers and Biosignatures: Converging Technologies, Emerging Partnerships: Workshop Summary (ISBN ) Miriam Davis, Sarah Hanson, Bruce Altevogt, Rapporteurs, Forum on Neuroscience and Nervous System Disorders, Institute of Medicine
- Genome-Based Therapeutics:Targeted Drug Discovery and Development: Workshop Summary (ISBN ) Adam C. Berger and Steve Olson, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine
- Generating Evidence for Genomic Diagnostic Test Development:Workshop Summary (ISBN ) Theresa Wizemann and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Institute of Medicine
- Genome-Based Diagnostics: Clarifying Pathways to Clinical Use: Workshop Summary (ISBN ) Steve Olson and Adam C. Berger, Rapporteurs; Roundtable on Translating Genomic-Based Research for Health; Board on Health Sciences Policy; Institute of Medicine
- Policy Issues in the Development of Personalized Medicine in Oncology:Workshop Summary (ISBN ) Margie Patlak and Laura Levit, Rapporteurs; Institute of Medicine
- Glutamate-Related Biomarkers in Drug Development for Disorders of the Nervous System: Workshop Summary (ISBN ) Diana E. Pankevich, Miriam Davis, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine
- Scientific Standards for Studies on Modified Risk Tobacco Products (ISBN ) Committee on Scientific Standards for Studies on Modified Risk Tobacco Products; Institute of Medicine
- Assessing and Improving Value in Cancer Care:Workshop Summary (ISBN ) Adam Schickedanz, Rapporteur; Institute of Medicine
- Rare Diseases and Orphan Products: Accelerating Research and Development (ISBN ) Marilyn J. Field and Thomas F. Boat, Editors; Committee on Accelerating Rare Diseases Research and Orphan Product Development; Institute of Medicine
- Saving Women's Lives: Strategies for Improving Breast Cancer Detection and Diagnosis (ISBN ) Janet E. Joy, Edward E. Penhoet, and Diana B. Petitti, Editors, Committee on New Approaches to Early Detection and Diagnosis of Breast Cancer, Institute of Medicine and National Research Council
- Federal Agency Roles in Cancer Drug Development from Preclinical Research to
New Drug Approval:
The National Cancer Institute and the Food and Drug Administration (ISBN )
- Accelerating the Development of New Drugs and Diagnostics: Maximizing the Impact of the Cures Acceleration Network: Workshop Summary (ISBN ) Steve Olson and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Board on Health Sciences Policy; Institute of Medicine
- Systems for Research and Evaluation for Translating Genome-Based Discoveries for Health:Workshop Summary (ISBN ) Theresa Wizemann, Rapporteur; Roundtable on Translating Genomic-Based Research for Health; Institute of Medicine
- Extending the Spectrum of Precompetitive Collaboration in Oncology Research:Workshop Summary (ISBN ) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; Institute of Medicine
- Challenges for the FDA: The Future of Drug Safety, Workshop Summary (ISBN ) Leslie Pray and Sally Robinson, Rapporteurs, Forum on Drug Discovery, Development, and Translation
- The National Cancer Policy Summit: Opportunities and Challenges in Cancer Research and Care: Workshop Summary (ISBN ) Margie Patlak, Sharyl J. Nass, and Erin Balogh, Rapporteurs; National Cancer Policy Forum; Institute of Medicine
- Building a National Framework for the Establishment of Regulatory Science for Drug Development:Workshop Summary (ISBN ) Yeonwoo Lebovitz, Rebecca English, and Anne Claiborne; Forum on Drug Discovery, Development, and Translation; Institute of Medicine
- Nanotechnology and Oncology: Workshop Summary (ISBN ) Margie Patlak and Christine Micheel, Rapporteurs; Institute of Medicine
- Evidence-Based Medicine and the Changing Nature of Health Care:Meeting Summary (IOM Roundtable on Evidence-Based Medicine) (ISBN ) Mark B. McClellan, J. Michael McGinnis, Elizabeth G. Nabel, and LeighAnne M. Olsen, Institute of Medicine
- Transforming Clinical Research in the United States:Challenges and Opportunities: Workshop Summary (ISBN ) Rebecca English, Yeonwoo Lebovitz, and Robert Griffin, authors; Forum on Drug Discovery, Development, and Translation; Institute of Medicine
- Diffusion and Use of Genomic Innovations in Health and Medicine:Workshop Summary (ISBN ) Lyla M. Hernandez, Rapporteur, Roundtable on Translating Genomic-Based Research for Health
- A Foundation for Evidence-Driven Practice:A Rapid Learning System for Cancer Care: Workshop Summary (ISBN ) Sharon Murphy and Margie Patlak, Rapporteurs; Institute of Medicine
- Future Opportunities to Leverage the Alzheimer's Disease Neuroimaging Initiative: Workshop Summary (ISBN ) Theresa Wizemann, Diana E. Pankevich, and Bruce M. Altevogt, Rapporteurs; Forum on Neuroscience and Nervous System Disorders; Institute of Medicine
- Advancing Regulatory Science for Medical Countermeasure Development: Workshop Summary (ISBN ) Theresa Wizemann, Bruce M. Altevogt, and Anne B. Claiborne, Rapporteurs; Forum on Drug Discovery, Development, and Translation; Forum on Medical and Public Health Preparedness for Catastrophic Events; Institute of Medicine
- Multi-Center Phase III Clinical Trials and NCI Cooperative Groups: Workshop Summary (ISBN ) Margie Patlak, Sharyl Nass, and Christine Micheel, Rapporteurs, Institute of Medicine
- Emerging Safety Science: Workshop Summary (ISBN ) Sally Robinson, Robert Pool, and Robert Giffin, Forum on Drug Discovery, Development, and Translation, Institute of Medicine
- Implementing a National Cancer Clinical Trials System for the 21st Century: Workshop Summary (ISBN ) Alison Mack and Sharyl J. Nass, Rapporteurs; National Cancer Policy Forum; Institute of Medicine; An American Society of Clinical Oncology and Institute of Medicine Workshop
|
|
|